Develops psilocybin therapies for mental health conditions.
Mar 2026Revenue $72.1K/yrExpenses $4.85M/yr
No trendCash runway ≈ 1.6 years from Jun 2026
Figures by year
When will Silo Pharma be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Mar 2026, revenue was $72.1K and expenses $4.85M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $72.1K | $4.35M | −$4.28M |
| Dec 2024 | $72.1K | $4.78M | −$4.71M |
| Dec 2023 | $72.1K | $3.93M | −$3.86M |
| Dec 2022 | $72.1K | $3.70M | −$3.63M |
| Dec 2020 | $40.9K | $2.24M | −$2.20M |
| Dec 2019 | $40.6K | $971K | −$930K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.